SnapShot: Nuclear Receptors I

Cell

Volumn 142, Issue 5, 2010, Pages

  McKenna, Neil J ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; ESTROGEN RECEPTOR; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; LIVER X RECEPTOR; MINERALOCORTICOID RECEPTOR; NUCLEAR RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PREGNANE X RECEPTOR; PROGESTERONE RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CELL RECEPTOR;

ADIPOCYTE; APOPTOSIS; CARBOHYDRATE METABOLISM; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRESS; DISEASE ASSOCIATION; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID OXIDATION; GLUCONEOGENESIS; HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; NONHUMAN; ORGANOGENESIS; OXYGEN CONSUMPTION; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEOMICS; REPRODUCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; VITAMIN METABOLISM; WOUND HEALING; ANIMAL; CHEMISTRY; DISEASES; GENETICS; METABOLISM;

ANIMALS; DISEASE; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77956149859     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.08.026     Document Type: Short Survey

References (10)

1. Flamant, F., Baxter, J.D., Forrest, D., Refetoff, S., Samuels, H., Scanlan, T.S., Vennström, B., and Samarut, J. (2006). International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol. Rev. 58, 705-711.
2. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Ström, A., Treuter, E., Warner, M., and Gustafsson, J.A. (2007). Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931.
3. Mark, M., Ghyselinck, N.B., and Chambon, P. (2009). Function of retinoic acid receptors during embryonic development. Nucl. Recept. Signal. 7, e002.
4. Moore, D.D., Kato, S., Xie, W., Mangelsdorf, D.J., Schmidt, D.R., Xiao, R., and Kliewer, S.A. (2006). International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. Pharmacol. Rev. 58, 742-759.
5. Nuclear Receptors Nomenclature Committee. (1999). A unified nomenclature system for the nuclear receptor superfamily. Cell 97, 161-163.
6. Pyper, S.R., Viswakarma, N., Yu, S., and Reddy, J.K. (2010). PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl. Recept. Signal. 8, e002.
7. Scarpin, K.M., Graham, J.D., Mote, P.A., and Clarke, C.L. (2009). Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl. Recept. Signal. 7, e009.
8. Sonoda, J., Pei, L., and Evans, R.M. (2008). Nuclear receptors: decoding metabolic disease. FEBS Lett. 582, 2-9.
9. Tontonoz, P., and Spiegelman, B.M. (2008). Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77, 289-312.
10. Zhou, C., Verma, S., and Blumberg, B. (2009). The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nucl. Recept. Signal. 7, e001